SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-136025
Filing Date
2023-05-04
Accepted
2023-05-04 16:43:10
Documents
16
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d298404d8k.htm   iXBRL 8-K 28988
2 EX-99.1 d298404dex991.htm EX-99.1 61680
7 GRAPHIC g298404dsp_01a.jpg GRAPHIC 13565
8 GRAPHIC g298404g0504205312799.jpg GRAPHIC 7806
  Complete submission text file 0001193125-23-136025.txt   288972

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20230504.xsd EX-101.SCH 3099
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20230504_def.xml EX-101.DEF 13862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20230504_lab.xml EX-101.LAB 22921
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20230504_pre.xml EX-101.PRE 14700
10 EXTRACTED XBRL INSTANCE DOCUMENT d298404d8k_htm.xml XML 5681
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 23889550
SIC: 2836 Biological Products, (No Diagnostic Substances)